沂蒙品牌怎么样 申请店铺

我要投票 沂蒙在玻璃胶行业中的票数:583 更新时间:2025-12-13
沂蒙是哪个国家的品牌?「沂蒙」是 山东省药用玻璃股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人扈永在1993-11-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力沂蒙品牌出海!将品牌入驻外推网,定制沂蒙品牌推广信息,可以显著提高沂蒙产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

沂蒙怎么样

山东省药用玻璃股份有限公司位于山东省沂源县城,这里是中国药用玻璃工业发源地之一,也是中国玻璃工业发达的地区。

山东省药用玻璃股份有限公司创立于1970年,以医药、食品、日用品行业为服务对象,生产各种药用、食品、日用品包装材料。2002年1月24日经中国证监会核准发行3200万股A股,并于2002年6月3日挂牌交易。

经过近40年的奋力拼搏,使山东药玻一步步成长为闻名世界的药用包装行业企业,产品市场覆盖32个省、市、自治区,并远销欧、美、俄、日、韩、东南亚等60多个国家和地区,每年为制药、食品、化妆工业提供百亿支各种规格的包装产品,这些产品中有模制抗生素瓶系列产品、管制瓶系列产品、棕色瓶系列产品、中性硼硅玻璃系列产品、输液瓶系列产品、日化瓶系列产品、食品瓶瓷砖 系列产品、丁基橡胶塞系列产品、预灌封注射器系列产品、铝塑盖系列产品、塑料瓶系列产品等,适用于制药工业粉针、水针、输液、口服液、冻干、生物制剂、片剂等不同药品制剂及食品、化妆品的包装需要,并有各种材质、瓶型及规格可供选择。其中公司的主导产品模制抗生素瓶年产量达90多亿支,药用丁基橡胶塞年产量48亿支,销往国内外各制药企业。

此外,山东药玻不断加大投入,采用最新科技,提高制造系列的自动化程度,完善生产工艺和质量控制手段,开发新的品种。引进了美国艾姆哈特行列式制瓶机生产线,实现了产品的自动检验和自动包装,提高了玻璃制品的成品率。强大的技术开发能力,不断满足用户的新需求成为可能。公司已现有科技成果172项,专利技术49项。

积40年从事药用玻璃制造的丰富经验和雄厚实力,山东药玻建立了完善的质量保证体系,对玻璃制造的每一个环节进行了严格的控制,在同行业中率先通过质量体系认证、环境体系认证和安全体系认证,并始终持续的改进保证体系,提升产品的品质,从而取得了和医药工业良好的配合,赢得了医药界人士的认可和赞赏。

Shandong Pharmaceutical Glass Co., Ltd. is located in Yiyuan County, Shandong Province, which is one of the birthplaces of China's pharmaceutical glass industry and the developed area of China's glass industry. Shandong Pharmaceutical Glass Co., Ltd. was founded in 1970, with the pharmaceutical, food, daily necessities industry as the service object, to produce a variety of pharmaceutical, food, daily necessities packaging materials. On January 24, 2002, China Securities Regulatory Commission approved the issuance of 32 million a shares, which was listed for trading on June 3, 2002. After nearly 40 years of hard work, Shandong Pharmaceutical glass has gradually grown into a world-famous pharmaceutical packaging industry enterprise. Its product market covers 32 provinces, cities and autonomous regions, and is exported to more than 60 countries and regions such as Europe, the United States, Russia, Japan, South Korea, Southeast Asia, etc. every year, it provides tens of billions of packaging products of various specifications for pharmaceutical, food and cosmetic industries, among which there are model antibiotics Bottle series products, control bottle series products, brown bottle series products, neutral borosilicate glass series products, infusion bottle series products, daily chemical bottle series products, food bottle ceramic tile series products, butyl rubber plug series products, pre filling syringe series products, aluminum plastic cover series products, plastic bottle series products, etc., suitable for powder injection, water injection, infusion, oral liquid in pharmaceutical industry , freeze-drying, biological agents, tablets and other different pharmaceutical preparations, food and cosmetics packaging needs, and a variety of materials, bottle types and specifications to choose from. Among them, the annual output of the company's leading product molding antibiotic bottles is more than 9 billion, and the annual output of medical butyl rubber plugs is 4.8 billion, which are sold to various pharmaceutical enterprises at home and abroad. In addition, Shandong Pharmaceutical glass has continuously increased investment, adopted the latest technology, improved the automation level of manufacturing series, improved production process and quality control means, and developed new varieties. The production line of American Emhart determinant bottle making machine is introduced to realize the automatic inspection and packaging of products and improve the yield of glass products. It is possible to continuously meet the new needs of users with powerful technology development capabilities. The company has 172 scientific and technological achievements and 49 patented technologies. With 40 years of rich experience and strong strength in pharmaceutical glass manufacturing, Shandong Pharmaceutical glass has established a perfect quality assurance system, strictly controlled every link of glass manufacturing, took the lead in the industry in passing the quality system certification, environmental system certification and safety system certification, and constantly improved the assurance system to improve the quality of products, so as to achieve and The good cooperation of the pharmaceutical industry has won the recognition and appreciation of the people in the pharmaceutical industry.

本文链接: https://brand.waitui.com/3548a554a.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

应对老年护理刚需,四部门发布《老年护理服务能力提升行动方案》

近日,国家卫生健康委、国家医保局、国家中医药局和国家疾控局四部门发布《老年护理服务能力提升行动方案》(以下简称《行动方案》)提出,到2027年,老年护理资源有效扩容,覆盖机构、社区、居家的老年护理服务体系逐步完善,从业人员服务能力不断提升,老年护理服务持续改善,服务连续性、可及性、规范性持续提高,老年人获得感不断增强。提升老年护理服务能力是深入贯彻实施积极应对人口老龄化国家战略的具体举措。截至2024年底,我国60岁及以上人口数达3.1亿,占总人口的22%,老年人特别是失能老年人对医疗护理服务呈现迫切的刚性需求。(央视新闻)

2小时前

消息人士称英伟达考虑提高H200芯片产量

消息人士称,英伟达考虑提高H200芯片产量。(新浪财经)

2小时前

中国造高端工业母机在沈阳下线交付

记者13日从通用技术沈阳机床获悉,由通用技术集团与东方电气集团联合研发的4台高端五轴联动数控机床12日在沈阳下线交付。这一合作在取得重大技术突破的同时,还打破了“研用脱节”的产业困境,开创了国产工业母机研制的新模式。长期以来,国产高端数控机床面临“研发投入大、周期长、验证难”的系统性瓶颈——企业闭门研发与市场实际需求脱节,产品因缺乏真实工况下的长期验证,陷入“用户不愿用、不敢用,技术难迭代、难成熟”的恶性循环,严重制约产业高质量发展。(中新网)

2小时前

金融时报:将坚持内需主导放在首位

金融时报评论员发布文章称,12月10日至11日,中央经济工作会议在京举行。会议聚焦“当前怎么看”和“明年怎么干”,为中国经济高质量发展把舵定向。站在“十四五”规划收官与“十五五”规划谋篇的历史交汇点,会议强调持续扩大内需、优化供给,将“坚持内需主导,建设强大国内市场”确定为明年经济工作重点任务之首。未来一个时期,我国国内市场主导国民经济循环的特征将更为明显。在内外部发展环境更趋严峻复杂的大背景下,只有坚持立足国内,全方位扩大内需、建设强大国内市场,增强发展主动性,才能够在国际风云变幻中,牢牢把握发展主动权。着眼明年经济社会发展目标任务,做强国内大循环,建设强大国内市场,以国内循环的稳定性对冲国际循环的不确定性,必须坚持内需的主导地位。坚持内需主导,全方位扩大国内需求,要大力提振居民消费。坚持内需主导,全方位扩大国内需求,要推动投资止跌回稳。将坚持内需主导放在首位,是党和国家对当前经济形势的深刻洞察。要全面贯彻明年经济工作的总体要求和政策取向,加快培育完整内需体系,形成消费和投资相互促进的良性循环,将超大规模市场的潜力转化为现实增长动力。

2小时前

脑虎科技:公司“三全”脑机接口产品成功完成首例临床试验

在今日举行的2025天桥脑科学研究院脑机接口与人工智能论坛中,脑虎科技方面表示,公司自主研发的国内首款、国际第二款内置电池的全植入、全无线、全功能(“三全”)脑机接口产品,在复旦大学附属华山医院毛颖、陈亮教授团队的主持下,成功完成首例临床试验。(财联社)

2小时前

本页详细列出关于沂蒙的品牌信息,含品牌所属公司介绍,沂蒙所处行业的品牌地位及优势。
咨询